M. Lenfant - Concepedia

Author

M. Lenfant

Institut de Chimie des Substances Naturelles ORCID

Also Known As

Lenfant, M, M Lenfant, M. LENFANT, M. Lenfant, Marc Lenfant

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Institut de Chimie des Substances Naturelles Centre National de la Recherche Scientifique Inserm Institut Gustave Roussy Maison des Sciences sociales et des Humanités de Dijon

About

M. Lenfant is an author at Institut de Chimie des Substances Naturelles specializing in medicine, biochemistry, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.3K
2	Biochemistry	9	9	851
3	Health Sciences	6	6	850
4	Natural Sciences	3	3	182
5	Engineering	1	1	50

M. Lenfant

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. Michel Azizi, A Rousseau, Éric Ezan, Journal of Clinical Investigation InflammationAce InhibitorBiochemistryMedicineVascular Pharmacology	1996	334
Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. M. Lenfant, Joanna Wdzieczak‐Bakala, Éric Guittet, Proceedings of the National Academy of Sciences Regenerative MedicineInduced Pluripotent Stem CellDevelopmental BiologyMedicineFive-step Purification Procedure	1989	243
Modulation of the interaction between G-actin and thymosin beta 4 by the ATP/ADP ratio: possible implication in the regulation of actin dynamics. M F Carlier, Catherine Jean, Klaus-Jörg Rieger, Proceedings of the National Academy of Sciences Atp/adp DependenceMolecular RegulationCytoskeletonCellular PhysiologyAtp/adp Ratio	1993	156
Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide <i>N</i>-acetyl-seryl-aspartyl-lysyl-proline Klaus-Jörg Rieger, Nathalie Saez-Servent, Marie Pierre Papet, Biochemical Journal Peptide TherapeuticsOxidative StressMolecular PharmacologyHematologyProtein Degradation	1993	110
Nitric oxide formation during microsomal hepatic denitration of glyceryl trinitrate: Involvement of cytochrome P-450 Denis Servent, M. Delaforge, Claire Ducrocq, Biochemical and Biophysical Research Communications HepatologyBiochemistryLiver PhysiologyPhysiologyCytochrome P-450	1989	108
Effect of heparin on the stimulation of non-vascular cells by human acidic and basic FGF Sylvie Uhlrich, O. Lagente, M. Lenfant, Biochemical and Biophysical Research Communications ThrombopoiesisThrombosisAngiogenesisHuman AcidicEndothelial Dysfunction	1986	84
Benzodiazepines and PK 11195 Exert Immunomodulating Activities by Binding on a Specific Receptor on Macrophages<sup>a</sup> Flora Zavala, M. Lenfant Annals of the New York Academy of Sciences InflammationMolecular PharmacologyMedicinePk 11195Immunology	1987	62
Deep Learning Versus Iterative Reconstruction for CT Pulmonary Angiography in the Emergency Setting: Improved Image Quality and Reduced Radiation Dose M. Lenfant, Olivier Chevallier, Pierre‐Olivier Comby, Diagnostics	2020	61
Nitroglycerin metabolism by Phanerochaete chrysosporium: evidence for nitric oxide and nitrite formation Denis Servent, Claire Ducrocq, Yann Henry, Biochimica et Biophysica Acta (BBA) - General Subjects Secondary MetabolismBiosynthesisEngineeringBiochemistryReactive Nitrogen Specie	1991	50
AcSDKP, an inhibitor of CFU-S proliferation, is synthesized in mice under steady-state conditions and secreted by bone marrow in long-term culture. Joanna Wdzieczak‐Bakala, Fache Mp, M. Lenfant, PubMed	1990	48

Page 1